Atherectomy Devices Market Size & Growth Forecast 2026–2035, By Segments (Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Atherectomy Devices Market size was more than USD 1.08 Billion in 2025 and is set to grow at a 8.1% CAGR between 2026 and 2035, crossing USD 2.35 Billion by 2035. The industry revenue for 2026 is estimated at USD 1.16 billion.
Get more details on this report
Request Free Sample ReportAtherectomy Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for 43.99% of the market in 2025, driven by mature cardiovascular care networks, high procedure volumes, and widespread clinician adoption for complex lesion preparation.
- Asia Pacific is forecast to expand at a 9.15% CAGR as access to minimally invasive vascular procedures improves and healthcare providers broaden capabilities for managing complex arterial blockages.
Segment Momentum
- Directional Atherectomy held a 38.05% share in 2025 because it provides controlled plaque removal and fits established treatment workflows for complex peripheral lesions requiring precise vessel preparation.
- Laser Atherectomy is the fastest-growing type as clinicians increasingly adopt it for managing complex calcified, fibrotic, and in-stent lesions that require greater procedural flexibility.
Market Expansion Drivers
- Rising prevalence of coronary and peripheral artery diseases driving procedural demand.
- Increasing adoption of minimally invasive vascular procedures improving clinical outcomes.
- Expansion of hybrid cath labs enabling advanced image-guided cardiovascular interventions.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Top companies in the atherectomy devices market include Boston Scientific Corporation (United States), Medtronic plc (Ireland), Abbott Laboratories (United States), Koninklijke Philips N.V. (Netherlands), Becton Dickinson and Company (United States), Terumo Corporation (Japan), AngioDynamics Inc. (United States), Cardinal Health Inc. (United States), Avinger Inc. (United States).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
A growing patient pool with calcified, complex, and diffusely narrowed vessels is directly increasing intervention volumes, which is driving demand for the atherectomy devices market. In clinical practice, coronary artery disease and peripheral artery disease often present with lesions that are difficult to treat effectively with balloon angioplasty alone, prompting physicians to use atherectomy to modify plaque before stenting or other endovascular steps. This transitions purchasing toward devices that can improve lesion preparation, support procedural success in challenging anatomy, and help interventional teams manage cases that would otherwise face higher rates of incomplete dilation or downstream complications.
Increasing adoption of minimally invasive vascular procedures improving clinical outcomes
The shift toward catheter-based treatment is driving market development for the atherectomy devices market as providers prioritize therapies that shorten hospital stays, reduce recovery time, and expand treatment eligibility for older and higher-risk patients. Atherectomy fits this care model by allowing targeted plaque removal through percutaneous access, which aligns with physician preference for less invasive workflows and hospital efforts to move more vascular interventions into efficient procedural settings. As minimally invasive care becomes the standard approach for many coronary and peripheral interventions, device selection increasingly favors technologies that can improve vessel preparation and support better immediate procedural results.
Expansion of hybrid cath labs enabling advanced image-guided cardiovascular interventions
Investment in hybrid cath labs is encouraging market growth for the atherectomy devices market by giving clinicians the infrastructure needed to perform more complex image-guided vascular procedures in a single integrated setting. These labs combine high-quality imaging, interventional equipment, and surgical backup, which makes operators more willing to treat heavily calcified or anatomically challenging lesions that benefit from atherectomy. In practice, this raises utilization by improving procedural confidence, enabling better visualization during plaque modification, and allowing hospitals to broaden the range of cardiovascular interventions they can manage without referring difficult cases elsewhere.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of PAD (Peripheral Artery Disease) | 3.10% | Short term (≤ 2 yrs) | North America, Europe (spillover: Asia Pacific) | High | Fast |
| Increasing adoption of minimally invasive atherectomy | 2.90% | Medium term (2–5 yrs) | Asia Pacific, North America (spillover: Europe) | Medium | Moderate |
| Advances in directional & orbital atherectomy devices | 2.10% | Long term (5+ yrs) | Europe, Asia Pacific (spillover: North America) | Medium | Slow |
| Rising prevalence of coronary and peripheral artery diseases driving procedural demand | 2.20% | High | North America, Europe, Asia Pacific | High | Near Term |
| Increasing adoption of minimally invasive vascular procedures improving clinical outcomes | 1.90% | High | North America, Asia Pacific | High | Mid Term |
| Expansion of hybrid cath labs enabling advanced image-guided cardiovascular interventions | 1.60% | Moderate | Europe, North America | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held a 43.99% share of the atherectomy devices market in 2025, bolstered by broad procedure adoption across established vascular care settings and consistent use of device-based interventions in peripheral and coronary artery disease management. The region’s leadership is sustained by mature hospital and ambulatory cardiovascular networks, higher procedural volumes, and clinician familiarity with atherectomy in complex lesion preparation, particularly where calcification can limit the effectiveness of conventional angioplasty alone. This operating environment supports recurring device demand through routine interventional practice rather than isolated uptake.
Asia Pacific is projected to expand at a 9.15% CAGR over the forecast period, with growth in the atherectomy devices market being propelled by increasing access to interventional vascular treatment and the gradual shift toward more advanced minimally invasive procedures. Adoption is accelerating as providers in major regional healthcare centers broaden their capability to manage complex arterial blockages with specialized devices, while expanding treatment capacity and rising procedural exposure improve comfort with atherectomy-based approaches in daily clinical use.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Vascular CareGermany prioritizes atherectomy technologies that integrate with advanced imaging and evidence-based vascular treatment pathways. Hospitals in Germany focus on device reliability and procedural precision while supporting complex peripheral artery disease management.
France 🇫🇷
Integrated Vascular TreatmentFrance supports atherectomy device adoption within multidisciplinary cardiovascular care programs focused on complex arterial disease. French healthcare institutions increasingly incorporate advanced endovascular technologies that improve treatment flexibility and procedural planning.
Italy 🇮🇹
Specialized Endovascular PracticeItaly continues expanding the use of atherectomy devices in specialized vascular centers treating peripheral artery disease. Clinical teams in Italy prioritize effective plaque removal technologies that complement balloon angioplasty and other minimally invasive interventions.
Japan 🇯🇵
Complex Lesion ManagementJapan continues adopting atherectomy devices for calcified vascular lesions requiring precise endovascular intervention. Clinicians in Japan emphasize device performance, procedural safety, and compatibility with minimally invasive treatment strategies for aging patient populations.
South Korea 🇰🇷
Innovation-Driven ProceduresSouth Korea strengthens atherectomy adoption through modern catheterization laboratories and increasing demand for minimally invasive vascular care. Healthcare providers in South Korea actively evaluate advanced plaque modification technologies that enhance clinical workflow and patient outcomes.
United States 🇺🇸
Advanced Intervention AdoptionThe U.S. atherectomy devices market emphasizes minimally invasive treatment for peripheral and coronary artery disease through technologically advanced plaque removal systems. Healthcare providers in the U.S. continue expanding image-guided procedures and outpatient vascular interventions to improve procedural efficiency.
Segment Leadership and Growth Trends
Atherectomy Devices Market Share (%), Type, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportDirectional Atherectomy held a 38.05% share of the atherectomy devices market in 2025, making it the leading type segment. Its position is aided by its practical value in plaque removal where physicians need controlled, targeted excision within complex peripheral lesions. That procedural control fits established treatment workflows and supports continued use in cases where vessel preparation and lumen gain are central clinical objectives, helping Directional Atherectomy retain its leadership in the atherectomy devices market.
Laser Atherectomy is emerging as the fastest-growing segment in the atherectomy devices market as treatment approaches increasingly favor technologies that can address difficult lesion morphology with precision and less dependence on mechanical cutting alone. Its growth momentum is tied to expanding clinical interest in handling challenging calcified, fibrotic, or in-stent lesions where operators seek greater procedural flexibility relative to conventional alternatives. As these requirements become more prominent in endovascular practice, Laser Atherectomy is gaining traction faster than other type segments.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | Directional Atherectomy, Rotational Atherectomy, Orbital Atherectomy, Laser Atherectomy | Directional Atherectomy | Laser Atherectomy |
Competitive Landscape and Market Positioning
1. Boston Scientific Corporation (United States)
2. Medtronic plc (Ireland)
3. Abbott Laboratories (United States)
4. Koninklijke Philips N.V. (Netherlands)
5. Becton Dickinson and Company (United States)
6. Terumo Corporation (Japan)
7. AngioDynamics Inc. (United States)
8. Cardinal Health Inc. (United States)
9. Avinger Inc. (United States)
The atherectomy devices market is advancing through continuous innovation focused on improving cardiovascular treatment outcomes and procedural precision. Device enhancements are increasingly centered on safety, efficiency, and minimally invasive performance. Strong R&D activity is supporting next-generation device development, while collaborative efforts are helping refine clinical usability and expand therapeutic applications.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Abbott | Apr-23 | Abbott completed the acquisition of Cardiovascular Systems, Inc., a specialist in atherectomy systems used for peripheral and coronary artery disease treatment. The integration adds orbital atherectomy technology to Abbott’s vascular portfolio, strengthening its minimally invasive intervention capabilities and expanding its offering across vessel preparation solutions used in angioplasty and stenting procedures globally. |
| Koninklijke Philips N.V. | Dec-21 | Koninklijke Philips N.V. acquired Vesper Medical Inc., a U.S.-based developer of minimally invasive peripheral vascular devices. The acquisition enhances Philips’ vascular intervention portfolio by incorporating venous stent technologies targeting deep venous disease, strengthening its position in the broader peripheral vascular and minimally invasive treatment market. |
| Avinger | Aug-24 | Avinger completed the commercial launch of its Pantheris LV image-guided directional atherectomy system for peripheral artery disease treatment in larger vessels, including the superficial femoral artery. The system features enhanced plaque excision speed and improved catheter control, expanding Avinger’s image-guided atherectomy portfolio and reinforcing its competitive positioning in above-the-knee interventions. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Atherectomy Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Atherectomy Devices Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchHow big is the atherectomy devices market?
How is the atherectomy devices industry projected to perform over the next decade?
How is the expansion of hybrid cath labs influencing adoption of advanced atherectomy procedures?
Why is the shift toward minimally invasive vascular interventions increasing demand for atherectomy devices?
Why is directional atherectomy the leading type in the atherectomy devices market?
Which atherectomy device type is growing fastest?
What factors support North America's leadership in the atherectomy devices market?
Why is Asia Pacific the fastest-growing region for atherectomy devices?
Who are the major participants shaping the atherectomy devices landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization